PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 217 filers reported holding PTC THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $211,464,973 | -23.4% | 9,436,188 | +39.0% | 0.04% | -19.2% |
| Q2 2023 | $276,001,424 | -18.6% | 6,786,364 | -3.0% | 0.05% | -22.4% |
| Q1 2023 | $338,968,152 | +19.5% | 6,997,691 | -5.8% | 0.07% | +17.5% |
| Q4 2022 | $283,637,721 | -24.6% | 7,430,907 | -0.8% | 0.06% | -28.8% |
| Q3 2022 | $376,052,000 | +33.5% | 7,491,062 | +6.5% | 0.08% | +40.4% |
| Q2 2022 | $281,762,000 | -7.3% | 7,033,505 | -13.7% | 0.06% | +9.6% |
| Q1 2022 | $304,097,000 | -6.4% | 8,150,541 | -0.1% | 0.05% | 0.0% |
| Q4 2021 | $324,816,000 | -0.4% | 8,155,047 | -7.0% | 0.05% | -5.5% |
| Q3 2021 | $326,214,000 | -11.6% | 8,766,827 | +0.4% | 0.06% | -9.8% |
| Q2 2021 | $369,075,000 | -15.2% | 8,731,392 | -5.0% | 0.06% | -20.8% |
| Q1 2021 | $435,164,000 | -23.6% | 9,190,357 | -1.6% | 0.08% | -26.7% |
| Q4 2020 | $569,952,000 | +28.7% | 9,338,879 | -1.4% | 0.10% | +14.1% |
| Q3 2020 | $442,849,000 | +8.8% | 9,472,736 | +18.1% | 0.09% | +1.1% |
| Q2 2020 | $407,123,000 | +46.3% | 8,023,699 | +28.6% | 0.09% | +23.0% |
| Q1 2020 | $278,285,000 | +518.2% | 6,238,168 | +565.6% | 0.07% | +722.2% |
| Q4 2019 | $45,014,000 | +70.9% | 937,189 | +20.3% | 0.01% | +50.0% |
| Q3 2019 | $26,341,000 | -37.7% | 778,848 | -17.2% | 0.01% | -33.3% |
| Q2 2019 | $42,308,000 | +23.0% | 940,175 | +2.9% | 0.01% | +12.5% |
| Q1 2019 | $34,400,000 | +11.6% | 913,936 | +1.8% | 0.01% | 0.0% |
| Q4 2018 | $30,815,000 | -25.7% | 897,849 | +1.7% | 0.01% | -11.1% |
| Q3 2018 | $41,485,000 | +33.5% | 882,659 | -4.2% | 0.01% | +28.6% |
| Q2 2018 | $31,086,000 | +40.6% | 921,615 | +12.8% | 0.01% | +40.0% |
| Q1 2018 | $22,115,000 | +58.0% | 817,240 | -2.6% | 0.01% | +66.7% |
| Q4 2017 | $14,001,000 | -39.1% | 839,367 | -27.0% | 0.00% | -40.0% |
| Q3 2017 | $22,992,000 | +16.4% | 1,149,037 | +6.7% | 0.01% | 0.0% |
| Q2 2017 | $19,745,000 | +90.8% | 1,077,202 | +2.4% | 0.01% | +150.0% |
| Q1 2017 | $10,349,000 | -73.3% | 1,051,657 | -70.4% | 0.00% | -80.0% |
| Q4 2016 | $38,804,000 | -40.4% | 3,556,626 | -23.5% | 0.01% | -37.5% |
| Q3 2016 | $65,123,000 | +101.7% | 4,648,386 | +1.1% | 0.02% | +100.0% |
| Q2 2016 | $32,282,000 | +6.7% | 4,598,539 | -2.2% | 0.01% | 0.0% |
| Q1 2016 | $30,267,000 | -70.5% | 4,699,733 | +48.4% | 0.01% | -70.4% |
| Q4 2015 | $102,613,000 | +95.2% | 3,167,021 | +60.9% | 0.03% | +80.0% |
| Q3 2015 | $52,561,000 | -50.3% | 1,968,596 | -10.5% | 0.02% | -44.4% |
| Q2 2015 | $105,818,000 | -24.3% | 2,198,606 | -4.3% | 0.03% | -25.0% |
| Q1 2015 | $139,748,000 | +15.7% | 2,296,583 | -1.6% | 0.04% | +12.5% |
| Q4 2014 | $120,791,000 | +17.6% | 2,333,209 | -0.0% | 0.03% | +14.3% |
| Q3 2014 | $102,687,000 | +159.4% | 2,333,256 | +54.1% | 0.03% | +154.5% |
| Q2 2014 | $39,591,000 | +3.9% | 1,514,572 | +3.9% | 0.01% | 0.0% |
| Q1 2014 | $38,090,000 | +52.7% | 1,457,157 | -0.9% | 0.01% | +57.1% |
| Q4 2013 | $24,945,000 | -31.5% | 1,469,945 | -13.4% | 0.01% | -36.4% |
| Q3 2013 | $36,414,000 | – | 1,696,817 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayer Capital Management, LP | 416,666 | $7,153,000 | 38.92% |
| Novo Holdings A/S | 747,359 | $11,210,000 | 2.78% |
| Bain Capital Public Equity Management, LLC | 2,333,333 | $50,073,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,027 | $18,134,000 | 0.84% |
| HealthCor Management, L.P. | 732,200 | $15,713,000 | 0.84% |
| RA Capital Management | 300,000 | $6,438,000 | 0.67% |
| Catalyst Capital Advisors LLC | 30,666 | $658,000 | 0.36% |
| CR Intrinsic Investors, LLC | 119,237 | $2,559,000 | 0.08% |
| Weiss Multi-Strategy Advisers LLC | 284,130 | $6,098,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 57,519 | $1,234,000 | 0.06% |